Literature DB >> 16308470

Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization.

Xu-Yu Yang1, Cai-Ping Ren, Lei Wang, Hui Li, Chun-Jie Jiang, Hong-Bo Zhang, Ming Zhao, Kai-Tai Yao.   

Abstract

BACKGROUND &
OBJECTIVE: Nasopharyngeal carcinoma (NPC) is an epithelial neoplasm with high occurrence rates in southern China. The disease often metastasizes to regional lymphnodes at a very early stage. Local recurrences and metastasis occur frequently in patients with NPC and are a leading cause of death, despite improvements on treatment modalities. The molecular mechanism underlying the metastasis of nasopharyngeal carcinoma remains poorly understood, however, and requires additional elucidation. The aim of this study was to explore possible NPC gene candidates that may play key roles in NPC metastasis.
METHODS: Subtractive suppression hybridization (SSH) was performed to isolate differentially expressed clones between the metastatic 5-8F and non-metastatic 6-10B nasopharyngeal carcinoma cell lines. Differentially expressed clones were screened and confirmed by reverse Northern blotting. The sequences of cDNA fragments were subsequently analyzed and compared to known sequences in Genbank. RESULTS & DISCUSSION: The SSH library contained thousands of positive clones. Random analysis of 300 clones by PCR demonstrated that 269 clones contained inserted fragments. Reverse Northern blot confirmed that 20 out of 192 clones examined were significantly up-regulated in the 5-8F cell line. Among these 20 clones, 16 were previously identified genes (flotilin-2, ezrin, pim-3, fli-1, mel, neugrin, znf216, ASB1, raly, UBE2A, keratin6A, TMED7, EIF3S9, FTL, two ribosomal proteins RPL21 and RPL16), two were predicted genes (c9orf74 and MDS006), and two sequences shared no homology with known genes listed in GenBank and may represent novel genes. The proposed functions of the genes identified in this study include cell signal transduction, cell survival, transcription regulation, cell mobility, protein synthesis, and DNA damage repair. Flotillin-2, fli-1, pim-3 and ezrin have previously been reported to be associated with tumor metastasis and progression. The remaining up-regulated genes identified in this study have not been reported to be markers of metastasis and may represent new candidates of NPC metastasis-related genes. The results of this study may provide novel points of therapeutic intervention for NPC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308470      PMCID: PMC4617502          DOI: 10.1155/2005/108490

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  31 in total

1.  Expression of ezrin in human embryonic, fetal, and normal adult tissues.

Authors:  Jian-Jun Xie; Fa-Ren Zhang; Li-Hua Tao; Zhuo Lü; Xiu-E Xu; Li-Yan Xu; En-Min Li
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

2.  Transcriptional and metabolic profiles of stress-induced, embryogenic tobacco microspores.

Authors:  Julia Hosp; Alisher Tashpulatov; Ute Roessner; Ekaterina Barsova; Heidrun Katholnigg; Ralf Steinborn; Balázs Melikant; Sergey Lukyanov; Erwin Heberle-Bors; Alisher Touraev
Journal:  Plant Mol Biol       Date:  2006-10-03       Impact factor: 4.076

3.  Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.

Authors:  Dapeng Xu; Michael G Cobb; Lily Gavilano; Sam M Witherspoon; Daniel Williams; Catherine D White; Pietro Taverna; Brian K Bednarski; Hong Jin Kim; Albert S Baldwin; Antonio T Baines
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

4.  The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the endosome upon LPS stimulation.

Authors:  Sarah L Doyle; Harald Husebye; Dympna J Connolly; Terje Espevik; Luke A J O'Neill; Anne F McGettrick
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

Review 5.  Roles of flotillins in tumors.

Authors:  Xu-Xu Liu; Wei-Dong Liu; Lei Wang; Bin Zhu; Xiao Shi; Zi-Xuan Peng; He-Cheng Zhu; Xing-Dong Liu; Mei-Zuo Zhong; Dan Xie; Mu-Sheng Zeng; Cai-Ping Ren
Journal:  J Zhejiang Univ Sci B       Date:  2018 Mar.       Impact factor: 3.066

6.  N,N'-dinitrosopiperazine-mediated ezrin protein phosphorylation via activation of Rho kinase and protein kinase C is involved in metastasis of nasopharyngeal carcinoma 6-10B cells.

Authors:  Faqing Tang; Feiyan Zou; Zhengke Peng; Damao Huang; Yuan Wu; Yu Chen; Chaojun Duan; Ya Cao; Wenhua Mei; Xiaowei Tang; Zigang Dong
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

7.  Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.

Authors:  Hua-Chuan Zheng; Koichi Tsuneyama; Hiroyuki Takahashi; Shigeharu Miwa; Toshiro Sugiyama; Boryana Konstantinova Popivanova; Chifumi Fujii; Kazuhiro Nomoto; Naofumi Mukaida; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-18       Impact factor: 4.553

8.  Mitochondrial proteomics of nasopharyngeal carcinoma metastasis.

Authors:  Jianping Liu; Xianquan Zhan; Maoyu Li; Guoqing Li; Pengfei Zhang; Zhefeng Xiao; Meiying Shao; Fang Peng; Rong Hu; Zhuchu Chen
Journal:  BMC Med Genomics       Date:  2012-12-06       Impact factor: 3.063

9.  FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.

Authors:  Qiuyuan Wen; Mohannad Ma Alnemah; Jiadi Luo; Weiyuan Wang; Shuzhou Chu; Lingjiao Chen; Jiao Li; Lina Xu; Meirong Li; Jianhua Zhou; Songqing Fan
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567.

Authors:  Faqing Tang; Dongsheng Wang; Chaojun Duan; Damao Huang; Yuan Wu; Yu Chen; Weiwei Wang; Chunlei Xie; Jingjing Meng; Lei Wang; Bin Wu; Shujin Liu; Daofa Tian; Feng Zhu; Zhiwei He; Fuliang Deng; Ya Cao
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.